UNSPSC 51392221: Detomidine hydrochloride for veterinary use

This classification denotes an alpha-adrenergic agonist with the molecular formula C12H14N2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 95K4LKB6QE, chemically known as 4-((2,3-dimethylphenyl)methyl)-1h-imidazole hydrochloride but more generally known as detomidine hydrochloride, which bears US NIH Compound Identifier 56031. European Medicines Agency schedules Detomidine hydrochloride for veterinary use in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11892MIG.

Most nations, for tariff and trade purposes, schedule detomidine hydrochloride for veterinary use under HS 29332990. SMILES: CC1CCCC(C1C)CC2C[NH]CN2.CL.

UNSPSC 51392221 Detomidine hydrochloride for veterinary use is a Commodity code that shows a significant mismatch between its nominal scope and recent state and local procurement activity. The single recent opportunity posted under this code — Seminole County, Florida's IFB 60459723LAS — solicits naloxone and drug deactivation systems for community health initiatives, not veterinary pharmaceuticals. The county is seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries required to the Seminole County Community Health Building in Sanford, Florida. Bidders must submit electronic proposals including unit costs, shipping, and delivery charges; comply with drug-free workplace certification and E-Verify requirements; maintain workers' compensation, commercial general liability, and professional liability insurance; and acknowledge a three-month probationary termination clause. The contract carries a two-year initial term with an optional one-year renewal and is potentially funded through FEMA, introducing federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act.

The code displays no relevant recent activity aligned with veterinary detomidine hydrochloride procurement. Seminole County is the sole issuing body in the recent-opportunities record, and the naloxone purchase represents a narrow public-health use case unrelated to the code's veterinary pharmaceutical purpose. With only one posted opportunity and no geographic or issuing-body pattern to characterize, the code warrants close review before pursuit — the tagging appears to be a data-entry or classification error rather than a signal of active veterinary-pharmaceutical demand among state and local buyers.